Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02197572
Title Effect of MLN0128 on the QTc Interval in Participants With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

Therapies

Sapanisertib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarasota Florida United States Details
Saint Louis Missouri United States Details
Bronx New York United States Details
Oklahoma City Oklahoma United States Details
Dallas Texas United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field